Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julio Hernandez

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Breast Cancer : Basic and Clinical Research|October 12, 2012
NGlycolylGM3/VSSP Vaccine in Metastatic Breast Cancer Patients: Results of Phase I/IIa Clinical TrialAna de la Torre, Julio Hernandez, Ramón Ortiz, et al.
Cancer Management and Research|October 12, 2012
Effect of vaccination with N-glycolyl GM3/VSSP vaccine by subcutaneous injection in patients with advanced cutaneous melanomaMarta Osorio, Elias Gracia, Edmundo Reigosa, et al.
International Journal of Environmental Research and Public Health|December 10, 2021
Evaluation of an Access-Risk-Knowledge (ARK) Platform for Governance of Risk and Change in Complex Socio-Technical SystemsNick McDonald, Lucy McKenna, Rebecca Vining, et al.
Renal Failure|August 7, 2025
Factors associated with successful transition from continuous renal replacement therapy in critically ill patients: a retrospective cohort studyRonald Miller, Abdel-Rauof Akkari, Ahmad Matarneh, et al.
Journal of the American College of Cardiology|April 18, 2020
Natural History and Risk Stratification in Andersen-Tawil Syndrome Type 1Andrea Mazzanti, Dmitri Guz, Alessandro Trancuccio, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Breast Cancer : Basic and Clinical Research|October 12, 2012
NGlycolylGM3/VSSP Vaccine in Metastatic Breast Cancer Patients: Results of Phase I/IIa Clinical TrialAna de la Torre, Julio Hernandez, Ramón Ortiz, et al.
Cancer Management and Research|October 12, 2012
Effect of vaccination with N-glycolyl GM3/VSSP vaccine by subcutaneous injection in patients with advanced cutaneous melanomaMarta Osorio, Elias Gracia, Edmundo Reigosa, et al.
International Journal of Environmental Research and Public Health|December 10, 2021
Evaluation of an Access-Risk-Knowledge (ARK) Platform for Governance of Risk and Change in Complex Socio-Technical SystemsNick McDonald, Lucy McKenna, Rebecca Vining, et al.
Renal Failure|August 7, 2025
Factors associated with successful transition from continuous renal replacement therapy in critically ill patients: a retrospective cohort studyRonald Miller, Abdel-Rauof Akkari, Ahmad Matarneh, et al.
Journal of the American College of Cardiology|April 18, 2020
Natural History and Risk Stratification in Andersen-Tawil Syndrome Type 1Andrea Mazzanti, Dmitri Guz, Alessandro Trancuccio, et al.
Pageof 3